
Inspire Medical Systems, Inc. (NYSE:INSP) reported second-quarter results and cut its FY25 guidance below estimates on Monday.
Inspire Medical Systems reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 21 cents per share. The company reported quarterly sales of $217.086 million which beat the analyst consensus estimate of $214.480 million.